tiprankstipranks
Trending News
More News >
Shanghai Pharmaceuticals Holding Co Ltd Class H (HK:2607)
:2607
Hong Kong Market

Shanghai Pharmaceuticals Holding Co (2607) Financial Statements

Compare
4 Followers

Shanghai Pharmaceuticals Holding Co Financial Overview

Shanghai Pharmaceuticals Holding Co's market cap is currently $65.69B. The company's EPS TTM is HK$0.3943826748; its P/E ratio is 9.38; and it has a dividend yield of 2.97%. Shanghai Pharmaceuticals Holding Co is scheduled to report earnings on April 28, 2025, and the estimated EPS forecast is HK$0.45. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 275.25B¥ 260.30B¥ 231.98B¥ 215.82B¥ 191.91B
Gross Profit¥ 30.63B¥ 30.93B¥ 30.49B¥ 28.54B¥ 27.44B
Operating Income¥ 8.14B¥ 7.67B¥ 9.01B¥ 8.21B¥ 7.18B
EBITDA¥ 12.06B¥ 10.90B¥ 12.44B¥ 10.55B¥ 10.44B
Net Income¥ 4.55B¥ 3.77B¥ 5.62B¥ 5.09B¥ 4.50B
Balance Sheet
Cash & Short-Term Investments¥ 44.38B¥ 40.67B¥ 37.01B¥ 22.39B¥ 22.30B
Total Assets¥ 221.21B¥ 211.97B¥ 198.13B¥ 163.44B¥ 149.19B
Total Debt¥ 47.79B¥ 42.90B¥ 38.56B¥ 31.69B¥ 31.79B
Net Debt¥ 12.05B¥ 12.38B¥ 11.16B¥ 9.30B¥ 9.50B
Total Liabilities¥ 137.47B¥ 131.65B¥ 120.13B¥ 104.37B¥ 94.44B
Stockholders' Equity¥ 71.68B¥ 68.52B¥ 67.06B¥ 49.36B¥ 45.35B
Cash Flow
Free Cash Flow¥ 3.43B¥ 2.26B¥ 2.06B¥ 942.55M¥ 3.83B
Operating Cash Flow¥ 5.83B¥ 5.23B¥ 4.74B¥ 5.06B¥ 6.84B
Investing Cash Flow¥ 415.98M¥ -2.49B---
Financing Cash Flow-¥ 231.85M¥ 12.14B¥ 1.57B-
Currency in CNY

Shanghai Pharmaceuticals Holding Co Earnings and Revenue History

Shanghai Pharmaceuticals Holding Co Debt to Assets

Shanghai Pharmaceuticals Holding Co Cash Flow

Shanghai Pharmaceuticals Holding Co Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis